Newegg Commerce Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Newegg Commerce Inc trades at $11.7 (market cap $243.30M), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 7.2× Newegg Commerce Inc's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Newegg Commerce Inc for 14 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| NEGG | NUVB | |
|---|---|---|
Market Cap | $243.30M | $1.74B |
Volume | 41,252 | 9,289,619 |
Sector | Consumer Cyclical | Health |
52-Week High | $92.74 | $9.54 |
52-Week Low | $11.49 | $3.41 |
Typical Hold Time | 14 Days | 1 Days |
Enterprise Value | $213.53M | $1.33B |
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $11.58, down 3.58% today, with a bearish technical outlook despite recent earnings beats. The company shows improving fundamentals with revenue stabilizing around $1.4B and net income turning positive in 2026 projections. Recent partnerships with Western Digital and HPE highlight strategic moves in AI and enterprise IT markets, while insider selling has created near-term pressure.
The stock presents a mixed picture with improving profitability but significant execution risks. While analyst consensus remains bullish with 100% buy ratings, the $7.75 price target suggests 33% downside from current levels. Key risks include volatile cash flows, competitive e-commerce pressures, and the need to sustain recent margin improvements.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →